echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > NDRC investigates cost ex factory price of foreign drugs or adjustment targets

    NDRC investigates cost ex factory price of foreign drugs or adjustment targets

    • Last Update: 2013-07-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2013-07-10 source: 21st century economic report although many organizations believe that the cost survey will bring a tide of drug price reduction, most of the enterprises contacted by journalists are optimistic On July 2, the drug price evaluation center of the national development and Reform Commission issued a document to investigate the cost and price of some enterprises Among them, the cost survey involves 27 well-known Chinese and foreign enterprises such as GlaxoSmithKline, Baite, anstelai, Yangtze River, etc., while the factory price survey covers 33 domestic enterprises such as Guangzhou Pharmaceutical, Zhongheng Wuzhou, Zhongsheng pharmaceutical, etc Since 2006, the national development and Reform Commission has organized a sample survey on the cost and ex factory price of pharmaceutical enterprises Almost every survey is accompanied by subsequent drug price reductions Liu Chang, a securities representative of Yuheng pharmaceutical, said: "the research has been conducted in the past few years But this year's policy background may remind many people of a new round of drug price cuts " Different from the previous survey, the survey includes more foreign pharmaceutical enterprises, which makes public opinion linked with the background that "foreign milk powder" has been asked to reduce its price recently IMS, the world's largest pharmaceutical market consulting and research institution, said it could lead to a 15-45% drop in sales revenue of multinational pharmaceutical companies On July 9, a person from the national development and Reform Commission told reporters: "the investigation of the ex factory price and cost of drugs is a routine action, which does not mean that the price of drugs will be adjusted." It is slightly different from the previous research This time, the national development and Reform Commission adopted the method of on-the-spot investigation, and sent personnel to various enterprises for spot check from July to October this year In the past, factory price declaration was conducted online, but on January 21 this year, the national development and Reform Commission urged 2959 enterprises to declare the factory price of drugs in 2011 More than 40% of pharmaceutical companies across the country fail to report the factory price before the deadline, which may cause the national development and Reform Commission to change the investigation method - field investigation can also block the false declaration Although many organizations believe that the cost survey will bring a tide of drug price reduction, most of the enterprises contacted by journalists are optimistic "I think it's neutral research," said Chen Deguang, deputy general manager of Kelun pharmaceutical I believe it will provide data for the next step of macro-control " But Liang Shujie, Secretary of the board of directors of Shuanglu Pharmaceutical Co., Ltd., who was investigated, said: "even if a new round of drug price reduction is not carried out, the retail price of drug terminals will be reduced by different ranges every time the bidding is conducted If there is not enough profit margin, new drug research and development will be weak " By the end of 2013, most enterprises will face the test of new GMP certification, which means a lot of hardware investment Executives of many domestic enterprises believe that the gross profit level of foreign varieties is on the high side If the next round of price reduction is inevitable, these foreign varieties are the objects of price adjustment "In recent years, the national development and Reform Commission has been studying the prices of foreign drugs, collecting some data comparing with the prices of the same drugs in other countries," said the national development and Reform Commission on July 9 At the beginning of this year, when an internal meeting of the drug R & D Committee of China Association of foreign invested enterprises talked about this topic, many foreign drug enterprise executives attributed it to taxes, marketing costs, etc After investigating Brazil, India and other countries, the national development and Reform Commission has grasped the prices of these drugs in other countries, and may set the highest retail prices in China "This subject has been in the research stage," said the NDRC official It's not easy to say when to launch it as a policy It needs comprehensive consideration " The composition of drug prices in foreign countries is also very complex, involving issues such as foreign taxes and reimbursement proportion of medical insurance, which need to be considered as a whole The national development and Reform Commission will not only focus on a few varieties of research, "some media say that how much a drug is more expensive abroad than at home, which is not the core of our concern." But price sampling is still aimed at a number of drugs "The NDRC hopes to improve the pricing method of cost plus of foreign varieties through cost investigation," said Zuo yuzeng, media director of rdpac "On average, the production and retail prices of China's original R & D drugs are lower than the international market prices, and the original R & D drugs still bear higher social responsibility and investment than the generic drugs," bringer told reporters We are concerned that further reduction of drug prices may lead to potential risks in drug quality control " However, since last year, Albania, Greece, Ireland and other countries have asked for the price reduction of imported drugs At present, China also reserves a large number of independent pricing rights for foreign funded original research drugs  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.